Hey warren as a fellow shareholder i understand your frustration the lack of communication can cause uncertainty between holders but the fact in the matter is the muzzle TF has on the company is still in effect and a rescheduled shareholder breifing should be after the 6 of September once collaboration results get announced and finally will have the opportunity to discuss findings. Also a sponsord webinar from TF presenting to people in the medical field seems positive with TF releasing reasearch where cell therapy needs to be which was inline with our collaboration.
PTX Price at posting:
6.7¢ Sentiment: Buy Disclosure: Held
